Literature DB >> 25200274

Depletion of protease-activated receptor 2 but not protease-activated receptor 1 may confer protection against osteoarthritis in mice through extracartilaginous mechanisms.

Miriam T Jackson1, Babak Moradi, Sanaa Zaki, Margaret M Smith, Sharon McCracken, Susan M Smith, Christopher J Jackson, Christopher B Little.   

Abstract

OBJECTIVE: To explore the involvement of protease-activated receptor 1 (PAR-1) and PAR-2 in the pathologic processes of osteoarthritis (OA) and to identify the cells/tissues primarily affected by ablation of PAR-1 or PAR-2 in mice.
METHODS: OA was induced in the joints of wild-type (WT), PAR-1(+/+) , PAR-1(-/-) , and PAR-2(-/-) mice by destabilization of the medial meniscus (DMM), and scores of histologic features (cartilage aggrecan loss and erosion, subchondral bone sclerosis, osteophytes, and synovitis) were compared at 1, 4, and 8 weeks post-DMM. The effects of PAR ablation on cartilage degradation and chondrocyte metalloproteinase expression/activity were studied in cultures of mouse femoral head tissue with or without interleukin-1α (IL-1α). At 1 week post-DMM, synovial expression of cytokines and metalloproteinase genes was measured by reverse transcription-polymerase chain reaction, and populations of inflammatory cells were quantified by flow cytometry.
RESULTS: Deletion of PAR-2, but not that of PAR-1, in mice significantly delayed the progression of cartilage damage and inhibited subchondral bone sclerosis following DMM. There was no inhibitory effect of PAR-1 or PAR-2 ablation on IL-1α-induced cartilage degradation or chondrocyte metalloproteinase expression/activation. A low but significant level of synovitis persisted in mice subjected to DMM compared to that in control mice subjected to sham surgery, but no differences between the genotypes were seen 4 or 8 weeks post-DMM. One week after DMM, increased synovial expression of proinflammatory cytokines and metalloproteinase genes, along with increased levels of CD4+ T cells, inflammatory monocytes, and activated macrophages, were seen in all genotypes. However, there was a significant reduction in the percentage of activated macrophages in PAR-2(-/-) mice compared to PAR-1(-/-) and WT mice.
CONCLUSION: Deletion of PAR-2, but not that of PAR-1, results in a significant decrease in DMM-induced cartilage damage. The chondroprotection in PAR-2(-/-) mice appears to occur indirectly through modulation of extracartilaginous events such as subchondral bone remodeling and synovial macrophage activation, rather than through alteration of chondrocyte catabolic responses.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25200274     DOI: 10.1002/art.38876

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  48 in total

Review 1.  Osteoarthritis year in review 2015: biology.

Authors:  A M Malfait
Journal:  Osteoarthritis Cartilage       Date:  2016-01       Impact factor: 6.576

2.  Microarray analyses of the dorsal root ganglia support a role for innate neuro-immune pathways in persistent pain in experimental osteoarthritis.

Authors:  R E Miller; P B Tran; S Ishihara; D Syx; D Ren; R J Miller; A M Valdes; A M Malfait
Journal:  Osteoarthritis Cartilage       Date:  2020-01-23       Impact factor: 6.576

3.  Can we target CCR2 to treat osteoarthritis? The trick is in the timing!

Authors:  R E Miller; A-M Malfait
Journal:  Osteoarthritis Cartilage       Date:  2017-02-09       Impact factor: 6.576

4.  Collagenolytic matrix metalloproteinases antagonize proteinase-activated receptor-2 activation, providing insights into extracellular matrix turnover.

Authors:  Adrian M D Falconer; Chun Ming Chan; Joseph Gray; Izuru Nagashima; Robert A Holland; Hiroki Shimizu; Andrew R Pickford; Andrew D Rowan; David J Wilkinson
Journal:  J Biol Chem       Date:  2019-05-19       Impact factor: 5.157

5.  Role of the C-C chemokine receptor-2 in a murine model of injury-induced osteoarthritis.

Authors:  L Longobardi; J D Temple; L Tagliafierro; H Willcockson; A Esposito; N D'Onofrio; E Stein; T Li; T J Myers; H Ozkan; M L Balestrieri; V Ulici; R F Loeser; A Spagnoli
Journal:  Osteoarthritis Cartilage       Date:  2016-11-14       Impact factor: 6.576

6.  The nociceptive innervation of the normal and osteoarthritic mouse knee.

Authors:  A M Obeidat; R E Miller; R J Miller; A-M Malfait
Journal:  Osteoarthritis Cartilage       Date:  2019-07-25       Impact factor: 6.576

7.  Spinal microglial activation in a murine surgical model of knee osteoarthritis.

Authors:  P B Tran; R E Miller; S Ishihara; R J Miller; A M Malfait
Journal:  Osteoarthritis Cartilage       Date:  2016-09-16       Impact factor: 6.576

Review 8.  MRI of synovitis and joint fluid.

Authors:  Christopher J Burke; Hamza Alizai; Luis S Beltran; Ravinder R Regatte
Journal:  J Magn Reson Imaging       Date:  2019-01-08       Impact factor: 4.813

9.  Reduced Osteoarthritis Severity in Aged Mice With Deletion of Macrophage Migration Inhibitory Factor.

Authors:  Meredith A Rowe; Lindsey R Harper; Margaret A McNulty; Anthony G Lau; Cathy S Carlson; Lin Leng; Richard J Bucala; Richard A Miller; Richard F Loeser
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

10.  Therapeutic effects of an anti-ADAMTS-5 antibody on joint damage and mechanical allodynia in a murine model of osteoarthritis.

Authors:  R E Miller; P B Tran; S Ishihara; J Larkin; A M Malfait
Journal:  Osteoarthritis Cartilage       Date:  2015-09-26       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.